Literature DB >> 17365658

Cellular physiology of retinal and choroidal arteriolar smooth muscle cells.

C N Scholfield1, J G McGeown, T M Curtis.   

Abstract

Control of ocular blood flow occurs predominantly at the level of the retinal and choroidal arterioles. The present article provides an overview of the Ca2 + handling mechanisms and plasmalemmal ion channels involved in the regulation of retinal and choroidal arteriolar smooth muscle tone. Increases in global intracellular free Ca2 + ([Ca2 +]i) involve multiple mechanisms, including agonist-dependent release of Ca2 + from intracellular stores through activation of the inositol trisphosphate (IP3) pathway. Ca2 + enters by voltage-dependent L-type Ca2 + channels and novel dihydropyridine-sensitive store-operated nonselective cation channels. Ca2 + extrusion is mediated by plasmalemmal Ca2 +-ATPases and through Na+/Ca2+ exchange. Local Ca2 + transients (Ca2 + sparks) play an important excitatory role, acting as the building blocks for more global Ca2 + signals that can initiate vasoconstriction. K+ and Cl- channels may also affect cell function by modulating membrane potential. The precise contribution of each of these mechanisms to the regulation of retinal and choroidal perfusion in vivo warrants future investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17365658     DOI: 10.1080/10739680601072115

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  15 in total

Review 1.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 2.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

3.  Purinergic control of vascular tone in the retina.

Authors:  Joanna Kur; Eric A Newman
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

4.  Feedback via Ca²⁺-activated ion channels modulates endothelin 1 signaling in retinal arteriolar smooth muscle.

Authors:  Michael Stewart; Maurice Needham; Peter Bankhead; Tom A Gardiner; C Norman Scholfield; Tim M Curtis; J Graham McGeown
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-17       Impact factor: 4.799

5.  Acute Hyperglycemia Reverses Neurovascular Coupling During Dark to Light Adaptation in Healthy Subjects on Optical Coherence Tomography Angiography.

Authors:  Changyow C Kwan; Hee Eun Lee; Gregory Schwartz; Amani A Fawzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

6.  cAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressin.

Authors:  Owen Jeffries; Mary K McGahon; Peter Bankhead; Maria Manfredi Lozano; C Norman Scholfield; Tim M Curtis; J Graham McGeown
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

7.  Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.

Authors:  Seungjun Lee; Norman R Harris
Journal:  Microcirculation       Date:  2008-07       Impact factor: 2.628

8.  Longitudinal imaging of microvascular remodelling in proliferative diabetic retinopathy using adaptive optics scanning light ophthalmoscopy.

Authors:  Toco Yuen Ping Chui; Alexander Pinhas; Alexander Gan; Moataz Razeen; Nishit Shah; Eric Cheang; Chun L Liu; Alfredo Dubra; Richard B Rosen
Journal:  Ophthalmic Physiol Opt       Date:  2016-01-24       Impact factor: 3.117

Review 9.  Retinovascular physiology and pathophysiology: new experimental approach/new insights.

Authors:  Donald G Puro
Journal:  Prog Retin Eye Res       Date:  2012-02-05       Impact factor: 21.198

10.  Ca2+-activated Cl- current in retinal arteriolar smooth muscle.

Authors:  Mary K McGahon; Maurice A Needham; C Norman Scholfield; J Graham McGeown; Tim M Curtis
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-04       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.